Studies on 3xTg-AD mice have shown no effect on tau phosphorylation after STZ administration [23]; however, other groups have reported similar findings to ours, in APP/PS1 mice [46], and also increased tau phosphorylation has been observed in different diabetic models (for review, see [10]). This evidence concerns the gene APP and Alzheimer disease.